Expression Profile of CYP1A1 and CYP1B1 Enzymes in Colon and Bladder Tumors-Reference-Cited by-同舟云学术

Expression Profile of CYP1A1 and CYP1B1 Enzymes in Colon and Bladder Tumors

Published:2013-12-16 Issue:12 Volume:8 Page:e82487
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Androutsopoulos Vasilis P.,Spyrou Ioannis,Ploumidis Achilles,Papalampros Alexandros Eystathios,Kyriakakis Michalis,Delakas Demetrios,Spandidos Demetrios A.,Tsatsakis Aristidis M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;J Ferlay;Eur J Cancer,2013

2. Estimates of the cancer incidence and mortality in Europe in 2006;J Ferlay;Ann Oncol,2007

3. Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer;CN Sternberg;Urology,2007

4. Antiproliferative effects of 5-fluorouracil and oxaliplatin in colon cancer cell lines: comparison of three different cytotoxicity assays;A Failli;J Biol Regul Homeost Agents,2013

5. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis;DW Nebert;Nat Rev Cancer,2006

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta-analysis identifies key genes and pathways implicated in Benzo[a]pyrene exposure response;Chemosphere;2024-09

2. Decoding the Role of CYP450 Enzymes in Metabolism and Disease: A Comprehensive Review;Biomedicines;2024-07-02

3. Carcinogenic effect of low doses of polycyclic and heterocyclic aromatic hydrocarbons and amines and lack of protection by inulin supplementation;Food and Chemical Toxicology;2024-03

4. Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study;Nucleosides, Nucleotides & Nucleic Acids;2023-12-20

5. Identification of Common Genes and Pathways Underlying Imatinib and Nilotinib Treatment in CML: a Bioinformatics Study;2023-08-31